CVS Health Corporation · NYSE:CVS
CVS Health — Caremark RX — Merger or Acquisition (February 2007)
20 slides from CVS Health's merger presentation, Feb 2, 2007
Slide 1: Cautionary Statement Regarding Forward-Looking Statements
Cautionary Statement Regarding Forward-Looking Statements This document contains certain forward-looking statements about CVS and Caremark. When used in this document, the words "anticipates", "may", "can", "believes", "expects", "projects", "intends", "likely", "will", "to be" and any similar expre
Slide 2: Important Information
Important Information CVS and Caremark have filed a joint proxy statement / prospectus with the SEC in connection with the proposed merger. CVS and Caremark urge investors and stockholders to read the joint proxy statement / prospectus and any other relevant documents filed by either party with the
Slide 3: Caremark Profile
Caremark Profile o Leading pharmaceutical services company providing comprehensive drug benefit services to health plan sponsors and their participants o Uniquely Integrated Services - PBM, Specialty, Disease Management o Clients - Corporate health plans - Managed care organizations and insurance co
Slide 4: Caremark Profile
Caremark Profile o Caremark retail network includes 60,000 pharmacies nationwide o Caremark operations - 7 mail pharmacies - 21 specialty pharmacies - 9 customer call centers - 12 client-site pharmacies - Industry's only FDA regulated repackaging plant o 13,000 employees, including 1,300 pharmacists
Slide 5: CVS Profile
CVS Profile o Nation's largest retail pharmacy with more than 6,200 retail and specialty stores in 43 states o Services - CVS/pharmacy stores - CVS.com - MinuteClinic - PharmaCare (PBM, Mail, Specialty services) o 170,000 employees, including 20,000 pharmacists o 2006 revenue $43.8 billion o 2006 pr
Slide 6: CVS Profile
CVS Profile 16% Share of U.S. Retail Scripts #1 or #2 market share in 75% of the top 100 markets in which CVS operates States with CVS/pharmacy Retail Stores PharmaCare Specialty Pharmacy Stores 7
Slide 7: CVS/Caremark Merger Overview
CVS/Caremark Merger Overview Name CVS/Caremark Corporation Symbol CVS (NYSE) Management Team Chairman: Mac Crawford President & CEO: Tom Ryan CFO: Dave Rickard President PBM: Howard McLure Board Composition 50/50 Split Headquarters Corporate: Woonsocket, RI PBM: Nashville, TN Expected Closing Februa
Slide 8: CVS/Caremark Governance Structure Upon Close
CVS/Caremark Governance Structure Upon Close o Provides for annual election of all directors o Will have majority voting provision o Separate CEO and Chairman o Has stock ownership guidelines for D&O o Allows stockholders to ratify auditors 9
Slide 9: Caremark Board Considered Consumer Strategy Superior to PBM Combination
Caremark Board Considered Consumer Strategy Superior to PBM Combination (Aug 2006) Strategic Significance High Low Consumer Strategy National Retail Chain Financial Significance PBM Low 10
Slide 10: CVS/Caremark Merger Capitalizes on Evolving Industry Trends
CVS/Caremark Merger Capitalizes on Evolving Industry Trends Market Trends CVS/Caremark Merger Benefit Growing Consumerism Gives consumers timely, actionable, personalized information to improve health outcomes Cost Shift to Consumer More transparency at point of sale - consumer able to make totally
Slide 11: CVS/Caremark Merger Enhances Shareholder Value
CVS/Caremark Merger Enhances Shareholder Value o 1.67 shares CVS/Caremark stock for each share of CMX o $2.00 special dividend to CMX shareholders of record Financial Benefits o Accretive repurchase of 150 million CVS/Caremark shares o $500 M in cost synergies, integration planning underway o $800 M
Slide 12: CVS/Caremark Merger Enhances Shareholder Value
CVS/Caremark Merger Enhances Shareholder Value o Clients overwhelmingly positive o Differentiated services will be compelling to payors Business Opportunity o Unmatched in-store services will increase consumer loyalty o February close creates opportunity for 2007 selling season o Substantial FCF wil
Slide 13: Near-Term Revenue Opportunities Unique to CVS/Caremark Combination
Near-Term Revenue Opportunities Unique to CVS/Caremark Combination o Incremental opportunities of $800 M to $1 B in 2008 - Half from PBM, half from retail o Revenue estimates based on market research and PharmaCare-CVS experience o Revenue synergy examples: - Improved access/services for PBM special
Slide 14: Caremark Board Concluded Express Proposal Not in Best Interests of Shareholders
Caremark Board of Directors Concluded that Express Proposal Not in Best Interests of Shareholders Strategic Rationale Does not create competitive advantages Defensive reaction out of concern about enhanced competition Constructed to disrupt CVS merger Financial Risk Review of recent filings show off
Slide 15: Express Scripts Proposal Includes Material Conditions
Express Scripts Proposal Includes Material Conditions A due diligence review Satisfaction of financing conditions Anti-trust and other regulatory approvals Approval by their own shareholders - a process they have not even begun and, which by their own admission, would prevent their illusory February
Slide 16: Value of Transactions for Caremark Shareholders
Value of Transactions for Caremark Shareholders Value Value of of 1/31/2007 Calculated as of Merger CVS ESRX Proposal Counterparty Stock Price $ 33.65 $ 69.52 * Exchange Ratio 1.67 0.426 Implied Value of Stock Consideration $ 56.20 $ 29.62 * Value of Dividend/Cash Consideration $ 2.00 $ 29.25 * Impl
Slide 17: Dispelling Myths
Dispelling Myths MYTH Incentive Alignment " CVS "makes money when patients and clients spend money" Financial Flexibility " ESRX would have "significant financial flexibility" Contract " "In past 3 years, twice as many Wins/Losses CMX clients have moved to ESRX than vice versa" Channel Choice " CVS/
Slide 18: CVS/Caremark Merger is in the Best Interests of Shareholders
CVS/Caremark Merger is in the Best Interests of Shareholders Immediate and concrete financial benefits February 2007 close Significant strategic benefits Clients supportive Proven management teams Highly conditional offer Financial benefits suspect Uncertain timing Lacks strategic rationale Client a
Slide 19: The CVS/Caremark Merger is in the Best Interest of Shareholders
The CVS/Caremark Merger is in the Best Interest of Shareholders February 2, 2007 20
Slide 20: Cautionary Statement Regarding Forward-Looking Statements
Cautionary Statement Regarding Forward-Looking Statements This document contains certain forward-looking statements about CVS and Caremark. When used in this document, the words “anticipates”, “may”, “can”, “believes”, “expects”, “projects”, “intends”, “likely”, “will”, “to be” and any similar expre